ArticleFrontiers in oncology2023

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment.

Wang Youlong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.